Nasdaq - Delayed Quote USD

Rydex Biotechnology Inv (RYOIX)

69.24 +0.82 (+1.20%)
As of 8:06 AM EDT. Market Open.
Loading Chart for RYOIX
DELL
  • Previous Close 68.42
  • YTD Return 0.80%
  • Expense Ratio 1.64%
  • Category Health
  • Last Cap Gain 42.00
  • Morningstar Rating
  • Morningstar Risk Rating High
  • Sustainability Rating
  • Net Assets 109.62M
  • Beta (5Y Monthly) 0.78
  • Yield 0.00%
  • 5y Average Return --
  • Holdings Turnover 61.00%
  • Last Dividend --
  • Inception Date Sep 1, 2004

Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.

Rydex Funds

Fund Family

Health

Fund Category

109.62M

Net Assets

2004-09-01

Inception Date

Performance Overview: RYOIX

Trailing returns as of 4/22/2024. Category is Health.

YTD Return

RYOIX
0.80%
Category
7.95%
 

1-Year Return

RYOIX
9.30%
Category
30.16%
 

3-Year Return

RYOIX
1.31%
Category
16.10%
 

5-Year Return

RYOIX
4.04%
Category
15.71%
 

People Also Watch

Holdings: RYOIX

Top 10 Holdings (40.72% of Total Assets)

SymbolCompany% Assets
ABBV
AbbVie Inc. 9.09%
AMGN
Amgen Inc. 5.75%
REGN
Regeneron Pharmaceuticals, Inc. 4.49%
VRTX
Vertex Pharmaceuticals Incorporated 4.20%
GILD
Gilead Sciences, Inc. 3.66%
CTVA
Corteva, Inc. 3.17%
MRNA
Moderna, Inc. 2.87%
AZN
AstraZeneca PLC 2.56%
BIIB
Biogen Inc. 2.53%
ILMN
Illumina, Inc. 2.41%

Sector Weightings

SectorRYOIX
Healthcare   96.83%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Related Mutual Fund News

Top Mutual Funds